Clovis Oncology Inc (CLVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLVS | BMY | AMGN | GILD | REGN |
| Company | Clovis Oncology Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.0808 | 44.75 | 312.89 | 64.72 | 970.00 |
| High | 0.0977 | 44.97 | 314.89 | 66.20 | 979.98 |
| Low | 0.0766 | 44.30 | 309.82 | 64.67 | 966.85 |
| Last | 0.0812 | 44.94 | 310.15 | 65.96 | 973.80 |
| Change | -0.0048 | +0.20 | -2.71 | +1.38 | +5.80 |
| % Change | -5.58% | +0.45% | -0.87% | +2.14% | +0.60% |
| Volume | 24,516,400 | 8,616,082 | 2,611,015 | 8,702,098 | 348,360 |
| 20-Day Average Volume | 9,433,500 | 14,036,977 | 2,897,411 | 7,514,636 | 484,879 |
| Previous Close | 0.0860 | 44.74 | 312.86 | 64.58 | 968.00 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.2340 | 46.01 | 281.65 | 65.99 | 919.07 |
| 20-Day Raw Stochastic | 1.73% | 25.37% | 81.15% | 35.27% | 95.43% |
| 20-Day Relative Strength | 23.83% | 36.74% | 66.53% | 38.91% | 61.63% |
| Weighted Alpha | -91.19 | -34.35 | +34.50 | -19.59 | +31.74 |
| Today's Opinion | 100% Sell | 100% Sell | 56% Buy | 100% Sell | 72% Buy |
| Previous Opinion | 100% Sell | 100% Sell | 56% Buy | 100% Sell | 72% Buy |
| Last Month's Opinion | 100% Sell | 56% Sell | 40% Sell | 100% Sell | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -39.04% since 12/13/22 | +2.10% since 05/03/24 | -0.12% since 05/03/24 | +1.55% since 05/03/24 | +1.90% since 05/03/24 |
| Low | 0.0760 on 12/16/22 | 43.49 on 05/09/24 | 297.52 on 05/06/24 | 64.34 on 05/06/24 | 950.27 on 05/06/24 |
| High | 0.1439 on 12/14/22 | 44.96 on 05/10/24 | 314.89 on 05/10/24 | 66.20 on 05/10/24 | 979.98 on 05/10/24 |
| 1-Month | |||||
| %Chg | -76.74% since 11/18/22 | -10.69% since 04/10/24 | +16.69% since 04/10/24 | -3.43% since 04/10/24 | +4.16% since 04/10/24 |
| Low | 0.0760 on 12/16/22 | 43.33 on 05/02/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 875.22 on 04/26/24 |
| High | 0.3772 on 12/01/22 | 50.58 on 04/11/24 | 322.60 on 05/03/24 | 69.03 on 04/11/24 | 979.98 on 05/10/24 |
| 3-Month | |||||
| %Chg | -92.75% since 09/20/22 | -9.83% since 02/09/24 | +6.80% since 02/09/24 | -10.70% since 02/09/24 | +2.28% since 02/09/24 |
| Low | 0.0760 on 12/16/22 | 43.33 on 05/02/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 875.22 on 04/26/24 |
| High | 1.3100 on 10/04/22 | 55.03 on 03/13/24 | 322.60 on 05/03/24 | 76.21 on 03/11/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | -93.12% since 06/17/22 | -11.26% since 11/10/23 | +16.32% since 11/10/23 | -13.35% since 11/10/23 | +22.06% since 11/10/23 |
| Low | 0.0760 on 12/16/22 | 43.33 on 05/02/24 | 260.52 on 11/21/23 | 64.33 on 05/03/24 | 784.96 on 11/15/23 |
| High | 3.2500 on 07/08/22 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 11,770 | 90,692,464 | 167,829,040 | 80,407,072 | 106,249,616 |
| Shares Outstanding, K | 144,955 | 2,027,100 | 536,435 | 1,245,077 | 109,762 |
| Annual Sales | 148,760,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 |
| Annual Net Income | -264,520,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 |
| Last Quarter Sales | 30,660,000 | 11,865,000,000 | 7,447,000,000 | 6,686,000,000 | 3,145,000,000 |
| Last Quarter Net Income | -56,010,000 | -11,911,000,000 | -113,000,000 | -4,170,000,000 | 722,000,000 |
| 60-Month Beta | 0.24 | 0.45 | 0.60 | 0.22 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.39 on 11/09/22 | -4.40 on 04/25/24 | 3.96 on 05/02/24 | -1.32 on 04/25/24 | 9.55 on 05/02/24 |
| Latest Earnings Date | 11/09/22 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 06/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 41.59 | 16.50 | 16.11 | 25.75 |